Rafferty Asset Management, LLC Citius Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $1,899 - $4,037	-2,159 Reduced 4.12%	50,243 $46,000
Q1 2022 May 13, 2022	SELL	$1.38 - $1.89 $460 - $631	-334 Reduced 0.63%	52,402 $94,000
Q4 2021 Feb 10, 2022	BUY	$1.51 - $2.2 $3,198 - $4,659	2,118 Added 4.18%	52,736 $81,000
Q3 2021 Nov 10, 2021	BUY	$1.74 - $2.6 $88,075 - $131,606	50,618 New	50,618 $103,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $457M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.